The U.S. Food and Drug Administration has announced a voluntary recall of Chantix after testing showed elevated nitrosamine levels in certain batches.

Nitrosamines occur naturally in some foods and water but can be harmful at higher levels, prompting regulatory attention worldwide.

In the recalled Chantix batches, detected nitrosamine levels exceeded the FDA’s recommended safety limits, leading to precautionary action to protect public health.

The recall is voluntary and coordinated with the manufacturer to remove affected lots, ensuring safety while maintaining public confidence in the drug supply.

Chantix has long been a trusted tool for smoking cessation, and its temporary unavailability may affect patients relying on it. Doctors and pharmacists are advised to contact affected patients, while users should consult healthcare providers about safe alternatives.

Patients are encouraged not to panic but to remain informed. Following guidance from medical professionals and the FDA ensures a safe path forward while continuing efforts to quit smoking successfully.